Definitive Contract 140D0426C0007
- Not listed
- This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Nirsense, Inc., a small disadvantaged business based in Richmond, Virginia. The contract, valued at $1,300,000.00, is for the development of an "ultra-thin helmet-compatible near-infrared spectroscopy (NIRS)/electroencephalography (EEG)-based cerebrovascular monitoring sensor system" to be integrated with future vertical lift operator state monitoring systems. The...
- This is a $250,000.00 firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Nirsense, Inc., doing business as Nirsense LLC, a small disadvantaged business. The contract is for the first phase of a Small Business Innovation Research (SBIR) program to develop an ultra-thin, helmet-compatible near-infrared spectroscopy (NIRS)-based cerebral and peripheral oxygenation sensor for future vertical lift operator state monitoring integration. The ultimate completion date for...
- The Defense Advanced Research Projects Agency (DARPA) awarded a $2.65 million Phase II Small Business Innovation Research (SBIR) contract to Nirsense, Inc., a small disadvantaged business based in Richmond, Virginia. The contract, awarded on January 1, 2025, with a completion date of June 30, 2026, supports the development of multimodal aircrew state assessment and augmentation technologies utilizing combined near-infrared spectroscopy, electroencephalography, and transcranial direct current...
- The U.S. Army Research Development and Engineering Command (RDECOM) awarded a definitive firm fixed-price contract valued at $733,000 to Nirsense, Inc., a Richmond, Virginia-based medical technology company specializing in advanced wearable sensor systems. The contract, awarded on March 22, 2023, with an ultimate completion date of January 30, 2026, supports research and development of electronic equipment with no set-aside designation. Nirsense, Inc., operating as a small disadvantaged...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $1,600,000.00 Firm Fixed Price Definitive Contract to Nirsense, Inc., a self-certified small disadvantaged business, to conduct research and development on a Small Business Innovation Research (SBIR) Phase II project titled "Multimodal Aircrew State Assessment and Augmentation." The contract has a completion date of January 2, 2024 and is set aside for small businesses. Nirsense, Inc. is a medical technology...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Nirsense, Inc., a small disadvantaged business. The $46,562 firm fixed price contract is for research and development of a near-infrared spectroscopy system to enable general hemodynamic tracking. Nirsense has previously provided research, development, and products to the Department of Defense, including a cerebral oximetry system for the Defense Health Agency and...
- This SBIR Phase I contract was awarded by the Defense Health Agency (DHA) to Nirsense, Inc., a small disadvantaged business and medical technology company that specializes in wearable sensor systems for measuring cerebral and somatic oxygenation. The $250,000 firm fixed price contract is for the development of a near-infrared spectroscopy (NIRS) and electroencephalography-enabled headband for unobtrusive microarousal detection and sleep quality estimation. This contract is part of Nirsense's...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order to Nirx Medical Technologies LLC, a minority-owned, small disadvantaged business, for the provision of a NIRX Functional Near-Infrared Spectroscopy (fNIRS) System and associated components. The total potential value of the contract is $264,677.50, and the period of performance runs through July 17, 2021. Nirx Medical Technologies is a leading provider...
- Biosensics LLC, a small business, has been awarded a $2,000,000.00 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences. The contract is for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, under the Small Business Innovation Research (SBIR) program. Biosensics LLC specializes in wearable devices for monitoring physical activity, gait, balance,...
- Biosensics LLC has been awarded a $325,000 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct research and development activities aligned with the agency's goals. Specifically, the contract calls for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, as outlined in NIH and CDC Solicitation A Solicitation of the National Institutes of...
Nirsense, Inc., a Richmond, Virginia-based small disadvantaged business specializing in advanced wearable sensor systems for physiological monitoring, was awarded a $600,000 firm fixed-price definitive contract by the National Institutes of Health on March 2, 2026. The contract is designated as a Total Small Business set aside and carries an ultimate completion date of March 1, 2027. Nirsense's core competency in near-infrared spectroscopy (NIRS) and multimodal sensor technologies positions the company to support NIH's research initiatives, likely involving the development or refinement of wearable systems for measuring cerebral and somatic oxygenation with applications across healthcare and clinical research settings. The award reflects Nirsense's established track record in federal research and development, particularly through prior Small Business Innovation Research contracts with defense and health-related agencies. While the company has historically concentrated its efforts on defense-oriented physiological monitoring applications, this NIH contract represents an opportunity to extend its sensor technology expertise into civilian healthcare research and development. The contract's firm fixed-price structure and modest ceiling value suggest a focused, well-defined scope of work that leverages the company's existing technological capabilities in advanced physiological monitoring systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $600.0k | 2/26/26 |